Sign In
Buy NUS
$5.28
-0.320 (-5.71%)
At Close: Jun 03, 2026
3 Overvalued Stocks to Sell Before the Bubble Bursts
07:00am, Wednesday, 03'rd Jul 2024
Finding overvalued stocks to sell is crucial for investors to safeguard their portfolios in today's erratic markets. Here, the emphasis is on three well-known businesses whose valuation measures have
Nu Skin (NUS) Troubled by Customer Acquisition Challenges
10:35am, Thursday, 20'th Jun 2024
Nu Skin (NUS) has been battling persistent macroeconomic headwinds across most regions, which has affected customer and affiliate acquisition.
The Vanity Trade: Two Stock Ideas (Nu Skin & Coty)
04:34pm, Tuesday, 11'th Jun 2024
Yesterday's daily market update mused about what will untie the Gordian Knot holding back the stock market from either crashing or rallying. While we wait, it feels like a great time to plan for futur
Escape the Downturn: 3 Must-Sell Stocks Before July
06:13am, Saturday, 08'th Jun 2024
In a market like this, you should identify stocks most likely to underperform as a way of protecting your portfolio. Some stocks have had poor performances in the past years but then they have some ve
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 07'th Jun 2024
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?
Expect gold's rally to resume in the latter half of 2024 and into 2025 – NUS's Xe Le
12:24pm, Thursday, 30'th May 2024
Jordan Finneseth is a Crypto Market Reporter for Kitco Crypto. Coming from a background in Psychology and Human Behavior, he began to focus his attention on the cryptocurrency space in early 2017 afte
Researchers and industry partners demonstrate cutting-edge chip technology for ultra-low power AI connected devices
10:59am, Monday, 20'th May 2024
Researchers from NUS, together with industry partners Soitec and NXP Semiconductors, have demonstrated a new class of silicon systems that promises to enhance the energy efficiency of AI connected dev
Nu Skin Releases 2023 Social Impact and Sustainability Report
04:10pm, Tuesday, 14'th May 2024
PROVO, Utah--(BUSINESS WIRE)--Nu Skin, a global leader in beauty and wellness, today released its 2023 Social Impact and Sustainability Report. The report outlines progress on the company's environmen
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
11:26am, Thursday, 09'th May 2024
Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.
Nu Skin Enterprises, Inc. (NUS) Q1 2024 Earnings Call Transcript
11:20pm, Wednesday, 08'th May 2024
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q1 2024Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President & CEO James Thomas - CFO Conference Cal
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
08:01pm, Wednesday, 08'th May 2024
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.37 per share a year ago.
Nu Skin (NUS) Q1 Earnings Coming Up: Factors to Consider
09:46am, Tuesday, 07'th May 2024
Nu Skin's (NUS) first-quarter 2024 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations are a concern.
For $15,000 in Passive Income, Invest $25,000 in These 7 Dividend Stocks
09:15am, Tuesday, 30'th Apr 2024
Work smarter, not harder, the saying goes. One way to do that is with passive income, which is derived from ownership rather than labor or active involvement in an enterprise.
Nu Skin Enterprises to Announce First Quarter 2024 Financial Results
04:05pm, Wednesday, 03'rd Apr 2024
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
11:02pm, Friday, 22'nd Mar 2024
Collaboration provides phase-appropriate plasmid DNA to support the development of engineered stem cells for cancer therapy WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories Internation
